These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12047649)

  • 1. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
    Grussendorf-Conen EI; Jacobs S
    Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities.
    Grussendorf-Conen EI; Jacobs S; Rübben A; Dethlefsen U
    Dermatology; 2002; 205(2):139-45. PubMed ID: 12218229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
    Vexiau D; Decuypère L; Moyse D; Aractingi S
    Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
    J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
    Zeng Y; Zheng YQ; Wang L
    J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional Laser-Assisted Topical Imiquimod 5% Cream Treatment for Recalcitrant Common Warts in Children: A Pilot Study.
    Park SM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
    Dermatol Surg; 2016 Dec; 42(12):1340-1346. PubMed ID: 27598444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plantar warts treated with an immune response modifier: a report of two cases.
    Zamiri M; Gupta G
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():45-7. PubMed ID: 14616815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
    Ahn CS; Huang WW
    Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imiquimod in the treatment of recalcitrant warts: a new therapy option?].
    Hesterberg U; Böhlen LM; Brand CU
    Praxis (Bern 1994); 2003 Mar; 92(12):535-9. PubMed ID: 12693144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical imiquimod for recalcitrant facial flat warts.
    Schwab RA; Elston DM
    Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
    Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
    Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
    Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
    Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
    Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
    Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of butcher's warts with imiquimod 5% cream.
    Poochareon V; Berman B; Villa A
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():42-4. PubMed ID: 14616814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream.
    Juschka U; Hartmann M
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():48-50. PubMed ID: 14616816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
    Sauder DN; Skinner RB; Fox TL; Owens ML
    Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.